Annual Total Long Term Liabilities
$20.81 B
-$2.30 B-9.94%
December 31, 2024
Summary
- As of February 25, 2025, TEVA annual total long term liabilities is $20.81 billion, with the most recent change of -$2.30 billion (-9.94%) on December 31, 2024.
- During the last 3 years, TEVA annual total long term liabilities has fallen by -$4.58 billion (-18.05%).
- TEVA annual total long term liabilities is now -47.42% below its all-time high of $39.58 billion, reached on December 31, 2016.
Performance
TEVA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$20.81 B
-$767.00 M-3.55%
December 31, 2024
Summary
- As of February 25, 2025, TEVA quarterly total long term liabilities is $20.81 billion, with the most recent change of -$767.00 million (-3.55%) on December 31, 2024.
- Over the past year, TEVA quarterly long term liabilities has stayed the same.
- TEVA quarterly long term liabilities is now -50.96% below its all-time high of $42.43 billion, reached on September 30, 2016.
Performance
TEVA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
TEVA Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.9% | 0.0% |
| 3 y3 years | -18.1% | 0.0% |
| 5 y5 years | -27.6% | 0.0% |
TEVA Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.1% | at low | -18.1% | at low |
| 5 y | 5-year | -27.6% | at low | -27.6% | at low |
| alltime | all time | -47.4% | >+9999.0% | -51.0% | >+9999.0% |
Teva Pharmaceutical Industries Limited Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $20.81 B(-9.9%) | $20.81 B(-3.6%) |
| Sep 2024 | - | $21.58 B(-0.7%) |
| Jun 2024 | - | $21.74 B(+1.4%) |
| Mar 2024 | - | $21.44 B(-7.2%) |
| Dec 2023 | $23.11 B(-3.5%) | $23.11 B(-0.3%) |
| Sep 2023 | - | $23.18 B(-1.5%) |
| Jun 2023 | - | $23.54 B(-3.6%) |
| Mar 2023 | - | $24.43 B(+2.0%) |
| Dec 2022 | $23.94 B(-5.7%) | $23.94 B(+3.2%) |
| Sep 2022 | - | $23.20 B(-7.6%) |
| Jun 2022 | - | $25.11 B(-0.3%) |
| Mar 2022 | - | $25.19 B(-0.8%) |
| Dec 2021 | $25.39 B(-3.9%) | $25.39 B(+3.3%) |
| Sep 2021 | - | $24.57 B(-2.5%) |
| Jun 2021 | - | $25.19 B(-2.9%) |
| Mar 2021 | - | $25.94 B(-1.8%) |
| Dec 2020 | $26.41 B(-8.1%) | $26.41 B(-2.3%) |
| Sep 2020 | - | $27.04 B(-4.8%) |
| Jun 2020 | - | $28.42 B(-0.0%) |
| Mar 2020 | - | $28.42 B(-1.1%) |
| Dec 2019 | $28.73 B(-6.0%) | $28.73 B(+1.8%) |
| Sep 2019 | - | $28.21 B(-5.1%) |
| Jun 2019 | - | $29.72 B(-0.9%) |
| Mar 2019 | - | $30.00 B(-1.8%) |
| Dec 2018 | $30.57 B(-10.0%) | $30.57 B(-1.7%) |
| Sep 2018 | - | $31.10 B(-7.0%) |
| Jun 2018 | - | $33.45 B(-2.6%) |
| Mar 2018 | - | $34.32 B(+1.1%) |
| Dec 2017 | $33.95 B(-14.2%) | $33.95 B(-12.6%) |
| Sep 2017 | - | $38.84 B(-5.9%) |
| Jun 2017 | - | $41.29 B(+4.2%) |
| Mar 2017 | - | $39.63 B(+0.1%) |
| Dec 2016 | $39.58 B(+250.2%) | $39.58 B(-6.7%) |
| Sep 2016 | - | $42.43 B(+269.4%) |
| Jun 2016 | - | $11.49 B(-1.2%) |
| Mar 2016 | - | $11.63 B(+2.9%) |
| Dec 2015 | $11.30 B(+4.9%) | $11.30 B(-11.3%) |
| Sep 2015 | - | $12.75 B(-0.5%) |
| Jun 2015 | - | $12.81 B(+8.5%) |
| Mar 2015 | - | $11.81 B(+9.6%) |
| Dec 2014 | $10.78 B(-16.5%) | $10.78 B(-4.4%) |
| Sep 2014 | - | $11.27 B(-0.2%) |
| Jun 2014 | - | $11.29 B(-9.4%) |
| Mar 2014 | - | $12.46 B(-3.5%) |
| Dec 2013 | $12.91 B(-13.1%) | $12.91 B(-3.0%) |
| Sep 2013 | - | $13.30 B(+1.9%) |
| Jun 2013 | - | $13.06 B(+1.2%) |
| Mar 2013 | - | $12.90 B(-13.2%) |
| Dec 2012 | $14.85 B(+5.2%) | $14.85 B(-6.5%) |
| Sep 2012 | - | $15.88 B(-0.6%) |
| Jun 2012 | - | $15.98 B(+17.2%) |
| Mar 2012 | - | $13.64 B(-3.4%) |
| Dec 2011 | $14.12 B(+118.8%) | $14.12 B(+105.9%) |
| Sep 2011 | - | $6.86 B(+7.8%) |
| Jun 2011 | - | $6.36 B(-12.1%) |
| Mar 2011 | - | $7.24 B(+12.1%) |
| Dec 2010 | $6.46 B(+0.1%) | $6.46 B(-19.4%) |
| Sep 2010 | - | $8.01 B(+4.8%) |
| Jun 2010 | - | $7.64 B(+26.8%) |
| Mar 2010 | - | $6.03 B(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $6.45 B(-20.0%) | $6.45 B(-4.6%) |
| Sep 2009 | - | $6.76 B(-5.6%) |
| Jun 2009 | - | $7.16 B(-5.0%) |
| Mar 2009 | - | $7.54 B(-6.5%) |
| Dec 2008 | $8.06 B(+88.3%) | $8.06 B(+57.9%) |
| Sep 2008 | - | $5.11 B(+14.9%) |
| Jun 2008 | - | $4.45 B(0.0%) |
| Mar 2008 | - | $4.45 B(+3.9%) |
| Dec 2007 | $4.28 B(-18.0%) | $4.28 B(-0.9%) |
| Sep 2007 | - | $4.32 B(-12.1%) |
| Jun 2007 | - | $4.91 B(-1.0%) |
| Mar 2007 | - | $4.96 B(-5.0%) |
| Dec 2006 | $5.22 B(+151.5%) | $5.22 B(-4.1%) |
| Sep 2006 | - | $5.45 B(+0.1%) |
| Jun 2006 | - | $5.44 B(-0.0%) |
| Mar 2006 | - | $5.44 B(+162.0%) |
| Dec 2005 | $2.08 B(+2.4%) | $2.08 B(+8.0%) |
| Sep 2005 | - | $1.92 B(-5.1%) |
| Jun 2005 | - | $2.03 B(+0.3%) |
| Mar 2005 | - | $2.02 B(-0.4%) |
| Dec 2004 | $2.03 B(+119.3%) | $2.03 B(+0.1%) |
| Sep 2004 | - | $2.02 B(-6.7%) |
| Jun 2004 | - | $2.17 B(-1.6%) |
| Mar 2004 | - | $2.21 B(+138.6%) |
| Dec 2003 | $924.90 M(-27.1%) | $924.90 M(+0.8%) |
| Sep 2003 | - | $917.50 M(-29.0%) |
| Jun 2003 | - | $1.29 B(+2.0%) |
| Mar 2003 | - | $1.27 B(-0.2%) |
| Dec 2002 | $1.27 B(-5.3%) | $1.27 B(-7.2%) |
| Sep 2002 | - | $1.37 B(-0.8%) |
| Jun 2002 | - | $1.38 B(+2.1%) |
| Mar 2002 | - | $1.35 B(+0.8%) |
| Dec 2001 | $1.34 B(+45.7%) | $1.34 B(-0.1%) |
| Sep 2001 | - | $1.34 B(+50.8%) |
| Jun 2001 | - | $889.41 M(-2.7%) |
| Mar 2001 | - | $913.68 M(-0.6%) |
| Dec 2000 | $918.88 M(+98.3%) | $918.88 M(+76.0%) |
| Sep 2000 | - | $522.00 M(+27.8%) |
| Jun 2000 | - | $408.40 M(-4.7%) |
| Mar 2000 | - | $428.68 M(-7.5%) |
| Dec 1999 | $463.46 M(+94.1%) | $463.46 M(+32.5%) |
| Sep 1999 | - | $349.90 M(+41.3%) |
| Jun 1999 | - | $247.70 M(+4.8%) |
| Mar 1999 | - | $236.40 M(-1.0%) |
| Dec 1998 | $238.80 M(+61.4%) | $238.80 M(+9.5%) |
| Sep 1998 | - | $218.00 M(+1.1%) |
| Jun 1998 | - | $215.70 M(+65.8%) |
| Mar 1998 | - | $130.10 M(-12.1%) |
| Dec 1997 | $148.00 M(-19.8%) | $148.00 M(-19.8%) |
| Dec 1996 | $184.50 M(+62.6%) | $184.50 M(+62.6%) |
| Dec 1995 | $113.50 M(+21.0%) | $113.50 M(+21.0%) |
| Dec 1994 | $93.80 M(+11.1%) | $93.80 M(+11.1%) |
| Dec 1993 | $84.40 M(+62.0%) | $84.40 M(+62.0%) |
| Dec 1992 | $52.10 M(-26.3%) | $52.10 M(-26.3%) |
| Dec 1991 | $70.70 M(-22.8%) | $70.70 M(-22.8%) |
| Dec 1990 | $91.60 M(+6.4%) | $91.60 M(+6.4%) |
| Dec 1989 | $86.10 M(+47.4%) | $86.10 M(+47.4%) |
| Dec 1988 | $58.40 M(+50.1%) | $58.40 M(+50.1%) |
| Mar 1987 | $38.90 M(-14.7%) | $38.90 M(-14.7%) |
| Mar 1986 | $45.60 M | $45.60 M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual total long term liabilities?
- What is the all time high annual total long term liabilities for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual total long term liabilities year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly long term liabilities year-on-year change?
What is Teva Pharmaceutical Industries Limited annual total long term liabilities?
The current annual total long term liabilities of TEVA is $20.81 B
What is the all time high annual total long term liabilities for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual total long term liabilities is $39.58 B
What is Teva Pharmaceutical Industries Limited annual total long term liabilities year-on-year change?
Over the past year, TEVA annual total long term liabilities has changed by -$2.30 B (-9.94%)
What is Teva Pharmaceutical Industries Limited quarterly total long term liabilities?
The current quarterly long term liabilities of TEVA is $20.81 B
What is the all time high quarterly long term liabilities for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly total long term liabilities is $42.43 B
What is Teva Pharmaceutical Industries Limited quarterly long term liabilities year-on-year change?
Over the past year, TEVA quarterly total long term liabilities has changed by $0.00 (0.00%)